ClinicalTrials.Veeva

Menu

Injection of Hormone to Enhance Implantation in Embryo Transfer After IVF

S

Servy Massey Fertility Insititute

Status

Completed

Conditions

Infertility

Treatments

Drug: HCG is introduced

Study type

Interventional

Funder types

Other

Identifiers

NCT01986374
HCG 2013

Details and patient eligibility

About

The endometrium is deprived of signals form the embryo in IVF conditions. Studies suggest that placing HCG into the uterus prior to embryo transfer can enhance implantation.

Full description

The study is in pilot phase, uncontrolled. The risks appear to be minimal and there are conflicting new reports being announced.

A small amount of fluid with HCG is injected into the uterus. HCG is a potent signal to the uterus for preparation for implantation.

This is not a funded study. Three published studies suggest the approach is valid; one refutes the concept.

Enrollment

75 patients

Sex

Female

Ages

21 to 47 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • infertility patients undergoing IVF with good expectation of two embryos day 3 or day 5. must speak and read English. Includes donor eggs.

Exclusion Criteria:abnormal uterus

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

75 participants in 1 patient group

HCG is introduced with small catheter.
Experimental group
Description:
phase 1 non randomized pilot
Treatment:
Drug: HCG is introduced

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems